ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionQuadrant Capital Group Llc
Latest Disclosed Ownership6,253 shares
Latest Disclosed Value $ 1,403,674
Quadrant Capital Group Llc reports 3.81% decrease in ownership of RMD / ResMed Inc.

On May 13, 2026 - Quadrant Capital Group Llc filed a 13F-HR/A form disclosing ownership of 6,253 shares of ResMed Inc. (MX:RMD) valued at $1,403,674 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 6,501 shares of ResMed Inc.. This represents a change in shares of -3.81% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 RESMED COM 761152107 6,253 -248 -3.81 1,404 -10.35 0.0420
2026-05-11 2026-03-31 13F RESMED COM 761152107 6,253 -248 49 0.0369
2026-02-12 2025-12-31 13F RESMED COM 761152107 6,501 4 0.06 1,566 -11.98 0.0473
2025-11-13 2025-09-30 13F RESMED COM 761152107 6,497 70 1.09 1,778 7.24 0.0578
2025-08-13 2025-06-30 13F RESMED COM 761152107 6,427 154 2.45 1,658 18.09 0.0597
2025-05-13 2025-03-31 13F RESMED COM 761152107 6,273 4,443 242.79 1,404 235.89 0.0522
2025-02-13 2024-12-31 13F RESMED COM 761152107 1,830 -81 -4.24 419 -10.30 0.0288
2024-11-12 2024-09-30 13F RESMED COM 761152107 1,911 26 1.38 467 29.44 0.0324
2024-08-12 2024-06-30 13F RESMED COM 761152107 1,885 44 2.39 361 -1.10 0.0268
2024-05-15 2024-03-31 13F RESMED COM 761152107 1,841 120 6.97 365 22.97 0.0288
2024-02-08 2023-12-31 13F RESMED COM 761152107 1,721 35 2.08 296 18.88 0.0254
2023-11-14 2023-09-30 13F RESMED COM 761152107 1,686 472 38.88 249 -6.04 0.0250
2023-08-10 2023-06-30 13F RESMED COM 761152107 1,214 -155 -11.32 265 -11.37 0.0263
2023-05-11 2023-03-31 13F RESMED COM 761152107 1,369 -77 -5.33 300 -0.33 0.0312
2023-02-13 2022-12-31 13F RESMED COM 761152107 1,446 -95 -6.16 301 -10.71 0.0341
2022-11-10 2022-09-30 13F RESMED COM 761152107 1,541 181 13.31 336 17.89 0.0444
2022-08-09 2022-06-30 13F RESMED COM 761152107 1,360 307 29.15 285 11.33 0.0383
2022-05-06 2022-03-31 13F RESMED COM 761152107 1,053 4 0.38 256 -6.23 0.0310
2022-02-01 2021-12-31 13F RESMED COM 761152107 1,049 -81 -7.17 273 -8.39 0.0326
2021-11-12 2021-09-30 13F RESMED COM 761152107 1,130 42 3.86 298 11.19 0.0416
2021-08-09 2021-06-30 13F RESMED COM 761152107 1,088 10 0.93 268 28.23 0.0389
2021-05-12 2021-03-31 13F RESMED COM 761152107 1,078 55 5.38 209 -3.69 0.0339
2021-02-16 2020-12-31 13F RESMED COM 761152107 1,023 164 19.09 217 47.62 0.0403
2020-11-13 2020-09-30 13F RESMED COM 761152107 859 9 1.06 147 -9.82 0.0320
2020-08-13 2020-06-30 13F RESMED COM 761152107 850 -742 -46.61 163 -30.34 0.0361
2020-05-15 2020-03-31 13F RESMED Com 761152107 1,592 91 6.06 234 4.93 0.0392
2020-03-19 2019-12-31 13F/A-1 RESMED Com 761152107 1,501 24 1.62 223 14.36 0.0269
2020-02-03 2019-12-31 13F RESMED Com 761152107 1,501 24 223 753.5461
2019-10-24 2019-09-30 13F RESMED COM 761152107 1,477 -105 -6.64 195 3.72 0.0300
2019-07-24 2019-06-30 13F RESMED COM 761152107 1,582 25 1.61 188 19.75 0.0297
2019-04-29 2019-03-31 13F RESMED COM 761152107 1,557 658 73.19 157 61.86 0.0276
2019-01-17 2018-12-31 13F RESMED COM 761152107 899 0 0.00 97 0.00 0.0259
2018-10-29 2018-09-30 13F RESMED COM 761152107 899 0 0.00 97 8.99 0.0277
2018-08-08 2018-06-30 13F RESMED COM 761152107 899 0 0.00 89 7.23 0.0312
2018-05-10 2018-03-31 13F RESMED COM 761152107 899 -3 -0.33 83 18.57 0.0301
2018-01-31 2017-12-31 13F RESMED COM 761152107 902 0 0.00 70 12.90 0.0279
2017-10-13 2017-09-30 13F ResMed COM 761152107 902 3 0.33 62 0.00 0.0256
2017-08-14 2017-06-30 13F ResMed COM 761152107 899 -128 -12.46 62 -13.89 0.0274
2017-04-10 2017-03-31 13F ResMed COM 761152107 1,027 64 6.65 72 24.14 0.0316
2017-01-11 2016-12-31 13F ResMed COM 761152107 963 -4 -0.41 58 -4.92 0.0291
2016-10-25 2016-09-30 13F ResMed COM 761152107 967 0 0.00 61 3.39 0.0398
2016-07-28 2016-06-30 13F ResMed COM 761152107 967 47 5.11 59 13.46 0.0406
2016-04-27 2016-03-31 13F ResMed COM 761152107 920 20 2.22 52 8.33 0.0337
2016-01-28 2015-12-31 13F ResMed COM 761152107 900 0 0.00 48 6.67 0.0332
2015-10-28 2015-09-30 13F ResMed COM 761152107 900 0 0.00 45 -10.00 0.0310
2015-08-12 2015-06-30 13F ResMed COM 761152107 900 900 50 0.0318
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.